Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). (Q44844685)
Jump to navigation
Jump to search
scientific article published in May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). |
scientific article published in May 2004 |
Statements
1 reference
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). (English)
1 reference
Cancer and Leukemia Group B
1 reference
Gregory A Otterson
1 reference
James E Herndon
1 reference
Dorothy Watson
1 reference
Mark R Green
1 reference
Hedy L Kindler
1 reference
1 reference
Identifiers
1 reference